Global Precision Medicine Market

1. Global Precision Medicine Market is estimated to reach US$ 126.14 Bn by 2027, growing at a CAGR of 12.48% during the forecasted period and was valued to have $XX Bn in 2019. Market Definition: Precision medicine also term 'personalized medicine' are designed for particular groups of patients and refers to the tailoring of medical treatment to optimize efficiency or therapeutic benefit, that allows physicians to adopt treatments that are more likely to relief patients based on the genetic understanding of their disease. Precision medicine also reduces the cost of treatment by reducing repetitive intake of medicine and diminishing the side-effects allied with them. The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis. Market Dynamics: The report estimates the growth rate of Precision Medicine Market and offers in-depth insights on market dynamics, drivers, restraints, challenges and threats till 2027. The complete information is based on primary and secondary research carried out in all the regions covered in the report. The growth of the Global Precision Medicine Market is evolving mainly because of increasing genome sequencing, New technologies like gene therapy and investments in precision medicine research and (R&D) by the major players also propelled the growth of the precision medicine market in the world, growing cancer prevalence and chronic infection and different (ADR), initiate the market growth, application of Nanomedicines can change disease managing for targeted drug delivery. Hence, reducing adverse side effects, growing government funding in precision medicine

2. initiatives and partnerships among software companies and pharmaceutical helps to drive the growth of the market. However, Developing accurate precision medicine at reasonable values can limit the growth of the market moreover, uneven infrastructure development across the region which becomes a challenging factor for developing countries for the growth of the precision medicine market and the shortage of skilled IT specialists in healthcare are anticipating to restrain market growth to a certain extent in the coming years. Recent industry developments: • In May 2018, Foundation Medicine proclaimed approval for Advanced Diagnostic Laboratory Test (ADLT) for Foundation One CDx for escalating its existing product portfolio. • In October 2018, Qiagen declared its launch of innovative RNA-seq library research solutions for next-generation sequencing. • Advancements in pharmacogenomics, Pharmacogenomics has the largest market share (24%) followed by genomics. contributes to maintaining the efficacy of a drug with the help of genetic evidence of persons. The genomics market is also predictable to grow at the highest CAGR of 13.67% during 2019–2027. • Furthermore, growing biopharmaceutical players to treat disease disorder like, cancer will drive the market growth positively. Global Precision Medicine Market,Market Segmentation: The report covers the brief analytical segments of the Precision Medicine Market thereby providing a wider view at the macro as well as micro levels. Based on application, Increasing incidence of cancer globally is likely to hold the major share for the treatment of cancers. Presently, several types of research and genetic tests are going on to develop Precision Medicine based on the patients. Precision medicine delivers a procedure to treat the patient based on the type of cancer, age, sex, adverse effect and other factors. Cancer detection is important for the physician to detect best- suited therapy to treat the person. In terms of end-use, Pharma & Biotech Companies estimated as the largest segment and valued to be around USD 22.2 Bn in 2019. The growth is accelerated by the availability of innovative

3. techniques with next-generation sequencing (NGS) for the recognition of drug-related genetic changes. Moreover, major players are involved in several investment programs for market growth. Global Precision Medicine Market,Regional analysis Geographically, North America dominated the growth of Precision Medicine Market with the largest share of 43%, followed by Europe with a 26% share and is expected to projected to reach US$ XX Bn by 2027, with a CAGR of XX% during the forecast period. This is attributed to promising government initiatives, the presence of well-developed healthcare infrastructure and the occurrence of cancer combined with the growing researches for the development of biomarkers within the region such as the US and Canada. Also, an increasing number of product approvals, and rising awareness regarding the benefits of precision medicine in the region. Asia-Pacific is estimated to be the fastest-growing region with the highest CAGR of 13% during the forecast period. Competitive Analysis: The competitive landscape section in the Precision Medicine Market highly fragmented and the offers various strategies such as agreements, new product launches, partnerships expansions, acquisitions, joint ventures, and other crucial aspects to lessen the competitive in the market. For instance, in October 2018, Microsoft Genomics merge partnered with Eagle Genomics to tackle the challenges of the genomics. The goal of the collaboration was to introduce the power and scale of the cloud to precision medicine, through the creation of fundamental research. Moreover, in January 2018, to accelerate the growth in the cancer segment, F. Hoffmann La Roche Ltd collaborated with Syapse. The objective of the report is to present a comprehensive analysis of the Global Precision Medicine Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision- makers. The report also helps in understanding Global Precision Medicine Market dynamics, structure by analyzing the market segments and projects the Global Precision Medicine Market size. Clear representation of competitive analysis of key players By Technology Type, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Precision Medicine Market make the report investor’s guide

4. Scope of the Global Precision Medicine Market: Global Precision Medicine Market, By Product types • Instruments • Consumables • Services Global Precision Medicine Market, By Technology Type • Transcriptomics • Genomic Sequencing • Epigenomics • Bioinformatics • Drug Discovery • Companion Diagnostics • Big Data Analytics Software • Other Technologies Global Precision Medicine Market, By Sequencing Technology type • Ion Semiconductor Sequencing • Pyrosequencing • Single Molecule Real Time Sequencing • Chain Termination Sequencing • Sequencing by Synthesis • Sequencing by Ligation • Nanopore Sequencing Global Precision Medicine Market,By Application Type • Oncology • Immunology • CNS

5. • Respiratory • Neurosciences • Infections • Pharmacogenomics • Rare Diseases • Other Global Precision Medicine Market, By End User • Pharma & Biotech Companies • Diagnostic Tool Companies • Big Data Companies • Clinical Laboratories • Healthcare Providers • Research Centers and Academic Institutes • Other Global Precision Medicine Market, by Region • North America • Europe • Asia Pacific • Middle East and Africa • Latin America Global Precision Medicine Market, key Players • ASEBIO • Biocrates Life Sciences AG • DxTerity Diagnostics Inc. • DxTerity Diagnostics Inc. • F. Hoffmann-La Roche Ltd • FOUNDATION MEDICINE • Intomics

6. • Laboratory Corporation of America Holdings • Menarini Silicon Biosystems • NanoString Technologies, Inc • NeoGenomics Laboratories • Novartis AG • Pfizer Inc • QIAGEN • Quest Diagnostics Incorporated • Tepnel Pharma Services (Hologic Inc.) • Teva Pharmaceutical • Randox Laboratories • Biomrieux Sa • Abbott Laboratories • Intel Corporation • Cepheid For more information of visit: https://www.maximizemarketresearch.com/market-report/global- precision-medicine-market/54172/ This report submitted by Maximize market Research Company Customization of the report: Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities. About Maximize Market Research: Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors. Contact info: Name: Lumawant Godage Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD. Email: sales@maximizemarketresearch.com : Omkar Heights,

7. Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India. Contact: +919607195908